Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,388,000 | 3,709,000 | 5,570,000 | 5,604,000 | 8,764,000 |
| Marketable Securities | N/A | 1,366,000 | N/A | N/A | N/A |
| Receivables | 10,605,000 | 10,323,000 | 10,703,000 | 10,915,000 | 10,861,000 |
| Inventories | 6,458,000 | 5,930,000 | 6,605,000 | 7,095,000 | 6,621,000 |
| Other current assets | 3,336,000 | 2,756,000 | 2,685,000 | 3,015,000 | 2,854,000 |
| TOTAL | $25,787,000 | $24,084,000 | $25,563,000 | $26,629,000 | $29,100,000 |
| Non-Current Assets | |||||
| PPE Net | 16,012,000 | 15,627,000 | 16,089,000 | 16,925,000 | 16,344,000 |
| Investments And Advances | 0 | 9,560,000 | 0 | 0 | 0 |
| Intangibles | 61,707,000 | 61,912,000 | 63,468,000 | 65,110,000 | 65,329,000 |
| Other Non-Current Assets | 15,905,000 | 6,313,000 | 16,257,000 | 17,251,000 | 16,445,000 |
| TOTAL | $93,624,000 | $93,412,000 | $95,814,000 | $99,286,000 | $98,118,000 |
| Total Assets | $119,411,000 | $117,496,000 | $121,377,000 | $125,915,000 | $127,218,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,698,000 | 6,374,000 | 10,154,000 | 13,581,000 | 16,581,000 |
| Accounts payable and accrued liabilities | 4,487,000 | 4,989,000 | 4,390,000 | 4,644,000 | 4,496,000 |
| Other current liabilities | 12,171,000 | 10,079,000 | 11,286,000 | 11,311,000 | 11,139,000 |
| TOTAL | $27,356,000 | $23,148,000 | $25,830,000 | $29,536,000 | $32,216,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,896,000 | 13,855,000 | 13,738,000 | 13,924,000 | 14,532,000 |
| Other Non-Current Liabilities | 14,936,000 | 7,757,000 | 15,644,000 | 15,340,000 | 15,079,000 |
| TOTAL | $28,854,000 | $28,408,000 | $29,406,000 | $29,286,000 | $29,662,000 |
| Total Liabilities | $56,210,000 | $51,556,000 | $55,236,000 | $58,822,000 | $61,878,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 1,016,000 | N/A | N/A | N/A |
| Retained earnings | N/A | 64,949,000 | N/A | N/A | N/A |
| Other shareholders' equity | 63,201,000 | 96,000 | 66,141,000 | 67,093,000 | 65,340,000 |
| TOTAL | $63,201,000 | $65,940,000 | $66,141,000 | $67,093,000 | $65,340,000 |
| Total Liabilities And Equity | $119,411,000 | $117,496,000 | $121,377,000 | $125,915,000 | $127,218,000 |